Report Detail
Global Critical Limb Ischemia Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030
- RnM3569068 |
- 02 September, 2024 |
- Global |
- 108 Pages |
- GIR (Global Info Research) |
- Service & Software
Critical limb ischemia (CLI) is a severe blockage in the arteries of the lower extremities, which markedly reduces blood-flow. It is a serious form of peripheral arterial disease, or PAD. PAD caused by atherosclerosis, the hardening and narrowing of the arteries over time due to the buildup of fatty deposits called plaque.Currently, the standard of care for patients battling CLI is balloon angioplasty, which relies on a small balloon delivered via a catheter to the blockage to compress it against the arterial wall, opening the vessel and restoring blood flow.
According to our (Global Info Research) latest study, the global Critical Limb Ischemia Treatment market size was valued at US$ 1864 million in 2023 and is forecast to a readjusted size of USD 3099 million by 2030 with a CAGR of 7.6% during review period.
Global critical limb ischemia treatment includes Medtronic, Boston Scientific, Abbott, COOK and Cardiovascular Systems, etc. Global top 3 companies hold a share over 59%. North America is the largest market, with a share about 39%, followed by Europe and Asia-Pacific with the share about 31% and 22%.
This report is a detailed and comprehensive analysis for global Critical Limb Ischemia Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Critical Limb Ischemia Treatment market size and forecasts, in consumption value ($ Million), 2019-2030
Global Critical Limb Ischemia Treatment market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Critical Limb Ischemia Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Critical Limb Ischemia Treatment market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Critical Limb Ischemia Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Critical Limb Ischemia Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific, Abbott, COOK, Cardiovascular Systems, Terumo, B. Braun, Biotronik, MicroPort Medical, Lepu Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Critical Limb Ischemia Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Critical Limb Ischemia Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Embolic Protection Devices
Peripheral Dilatation Systems
Drugs Treatment
Other
Market segment by Application
ASCs
Hospitals
Catheterization Laboratory
Market segment by players, this report covers
Medtronic
Boston Scientific
Abbott
COOK
Cardiovascular Systems
Terumo
B. Braun
Biotronik
MicroPort Medical
Lepu Medical
Micro Medical Solutions
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Critical Limb Ischemia Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Critical Limb Ischemia Treatment, with revenue, gross margin, and global market share of Critical Limb Ischemia Treatment from 2019 to 2024.
Chapter 3, the Critical Limb Ischemia Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Critical Limb Ischemia Treatment market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Critical Limb Ischemia Treatment.
Chapter 13, to describe Critical Limb Ischemia Treatment research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Critical Limb Ischemia Treatment by Type
- 1.3.1 Overview: Global Critical Limb Ischemia Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Critical Limb Ischemia Treatment Consumption Value Market Share by Type in 2023
- 1.3.3 Embolic Protection Devices
- 1.3.4 Peripheral Dilatation Systems
- 1.3.5 Drugs Treatment
- 1.3.6 Other
- 1.4 Global Critical Limb Ischemia Treatment Market by Application
- 1.4.1 Overview: Global Critical Limb Ischemia Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 ASCs
- 1.4.3 Hospitals
- 1.4.4 Catheterization Laboratory
- 1.5 Global Critical Limb Ischemia Treatment Market Size & Forecast
- 1.6 Global Critical Limb Ischemia Treatment Market Size and Forecast by Region
- 1.6.1 Global Critical Limb Ischemia Treatment Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Critical Limb Ischemia Treatment Market Size by Region, (2019-2030)
- 1.6.3 North America Critical Limb Ischemia Treatment Market Size and Prospect (2019-2030)
- 1.6.4 Europe Critical Limb Ischemia Treatment Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Critical Limb Ischemia Treatment Market Size and Prospect (2019-2030)
- 1.6.6 South America Critical Limb Ischemia Treatment Market Size and Prospect (2019-2030)
- 1.6.7 Middle East & Africa Critical Limb Ischemia Treatment Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Medtronic
- 2.1.1 Medtronic Details
- 2.1.2 Medtronic Major Business
- 2.1.3 Medtronic Critical Limb Ischemia Treatment Product and Solutions
- 2.1.4 Medtronic Critical Limb Ischemia Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Medtronic Recent Developments and Future Plans
- 2.2 Boston Scientific
- 2.2.1 Boston Scientific Details
- 2.2.2 Boston Scientific Major Business
- 2.2.3 Boston Scientific Critical Limb Ischemia Treatment Product and Solutions
- 2.2.4 Boston Scientific Critical Limb Ischemia Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Boston Scientific Recent Developments and Future Plans
- 2.3 Abbott
- 2.3.1 Abbott Details
- 2.3.2 Abbott Major Business
- 2.3.3 Abbott Critical Limb Ischemia Treatment Product and Solutions
- 2.3.4 Abbott Critical Limb Ischemia Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Abbott Recent Developments and Future Plans
- 2.4 COOK
- 2.4.1 COOK Details
- 2.4.2 COOK Major Business
- 2.4.3 COOK Critical Limb Ischemia Treatment Product and Solutions
- 2.4.4 COOK Critical Limb Ischemia Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 COOK Recent Developments and Future Plans
- 2.5 Cardiovascular Systems
- 2.5.1 Cardiovascular Systems Details
- 2.5.2 Cardiovascular Systems Major Business
- 2.5.3 Cardiovascular Systems Critical Limb Ischemia Treatment Product and Solutions
- 2.5.4 Cardiovascular Systems Critical Limb Ischemia Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Cardiovascular Systems Recent Developments and Future Plans
- 2.6 Terumo
- 2.6.1 Terumo Details
- 2.6.2 Terumo Major Business
- 2.6.3 Terumo Critical Limb Ischemia Treatment Product and Solutions
- 2.6.4 Terumo Critical Limb Ischemia Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Terumo Recent Developments and Future Plans
- 2.7 B. Braun
- 2.7.1 B. Braun Details
- 2.7.2 B. Braun Major Business
- 2.7.3 B. Braun Critical Limb Ischemia Treatment Product and Solutions
- 2.7.4 B. Braun Critical Limb Ischemia Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 B. Braun Recent Developments and Future Plans
- 2.8 Biotronik
- 2.8.1 Biotronik Details
- 2.8.2 Biotronik Major Business
- 2.8.3 Biotronik Critical Limb Ischemia Treatment Product and Solutions
- 2.8.4 Biotronik Critical Limb Ischemia Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Biotronik Recent Developments and Future Plans
- 2.9 MicroPort Medical
- 2.9.1 MicroPort Medical Details
- 2.9.2 MicroPort Medical Major Business
- 2.9.3 MicroPort Medical Critical Limb Ischemia Treatment Product and Solutions
- 2.9.4 MicroPort Medical Critical Limb Ischemia Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 MicroPort Medical Recent Developments and Future Plans
- 2.10 Lepu Medical
- 2.10.1 Lepu Medical Details
- 2.10.2 Lepu Medical Major Business
- 2.10.3 Lepu Medical Critical Limb Ischemia Treatment Product and Solutions
- 2.10.4 Lepu Medical Critical Limb Ischemia Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 Lepu Medical Recent Developments and Future Plans
- 2.11 Micro Medical Solutions
- 2.11.1 Micro Medical Solutions Details
- 2.11.2 Micro Medical Solutions Major Business
- 2.11.3 Micro Medical Solutions Critical Limb Ischemia Treatment Product and Solutions
- 2.11.4 Micro Medical Solutions Critical Limb Ischemia Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.11.5 Micro Medical Solutions Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Critical Limb Ischemia Treatment Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Critical Limb Ischemia Treatment by Company Revenue
- 3.2.2 Top 3 Critical Limb Ischemia Treatment Players Market Share in 2023
- 3.2.3 Top 6 Critical Limb Ischemia Treatment Players Market Share in 2023
- 3.3 Critical Limb Ischemia Treatment Market: Overall Company Footprint Analysis
- 3.3.1 Critical Limb Ischemia Treatment Market: Region Footprint
- 3.3.2 Critical Limb Ischemia Treatment Market: Company Product Type Footprint
- 3.3.3 Critical Limb Ischemia Treatment Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Critical Limb Ischemia Treatment Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Critical Limb Ischemia Treatment Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Critical Limb Ischemia Treatment Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Critical Limb Ischemia Treatment Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Critical Limb Ischemia Treatment Consumption Value by Type (2019-2030)
- 6.2 North America Critical Limb Ischemia Treatment Market Size by Application (2019-2030)
- 6.3 North America Critical Limb Ischemia Treatment Market Size by Country
- 6.3.1 North America Critical Limb Ischemia Treatment Consumption Value by Country (2019-2030)
- 6.3.2 United States Critical Limb Ischemia Treatment Market Size and Forecast (2019-2030)
- 6.3.3 Canada Critical Limb Ischemia Treatment Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Critical Limb Ischemia Treatment Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Critical Limb Ischemia Treatment Consumption Value by Type (2019-2030)
- 7.2 Europe Critical Limb Ischemia Treatment Consumption Value by Application (2019-2030)
- 7.3 Europe Critical Limb Ischemia Treatment Market Size by Country
- 7.3.1 Europe Critical Limb Ischemia Treatment Consumption Value by Country (2019-2030)
- 7.3.2 Germany Critical Limb Ischemia Treatment Market Size and Forecast (2019-2030)
- 7.3.3 France Critical Limb Ischemia Treatment Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Critical Limb Ischemia Treatment Market Size and Forecast (2019-2030)
- 7.3.5 Russia Critical Limb Ischemia Treatment Market Size and Forecast (2019-2030)
- 7.3.6 Italy Critical Limb Ischemia Treatment Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Critical Limb Ischemia Treatment Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Critical Limb Ischemia Treatment Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Critical Limb Ischemia Treatment Market Size by Region
- 8.3.1 Asia-Pacific Critical Limb Ischemia Treatment Consumption Value by Region (2019-2030)
- 8.3.2 China Critical Limb Ischemia Treatment Market Size and Forecast (2019-2030)
- 8.3.3 Japan Critical Limb Ischemia Treatment Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Critical Limb Ischemia Treatment Market Size and Forecast (2019-2030)
- 8.3.5 India Critical Limb Ischemia Treatment Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Critical Limb Ischemia Treatment Market Size and Forecast (2019-2030)
- 8.3.7 Australia Critical Limb Ischemia Treatment Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Critical Limb Ischemia Treatment Consumption Value by Type (2019-2030)
- 9.2 South America Critical Limb Ischemia Treatment Consumption Value by Application (2019-2030)
- 9.3 South America Critical Limb Ischemia Treatment Market Size by Country
- 9.3.1 South America Critical Limb Ischemia Treatment Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Critical Limb Ischemia Treatment Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Critical Limb Ischemia Treatment Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Critical Limb Ischemia Treatment Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Critical Limb Ischemia Treatment Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Critical Limb Ischemia Treatment Market Size by Country
- 10.3.1 Middle East & Africa Critical Limb Ischemia Treatment Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Critical Limb Ischemia Treatment Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Critical Limb Ischemia Treatment Market Size and Forecast (2019-2030)
- 10.3.4 UAE Critical Limb Ischemia Treatment Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Critical Limb Ischemia Treatment Market Drivers
- 11.2 Critical Limb Ischemia Treatment Market Restraints
- 11.3 Critical Limb Ischemia Treatment Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Critical Limb Ischemia Treatment Industry Chain
- 12.2 Critical Limb Ischemia Treatment Upstream Analysis
- 12.3 Critical Limb Ischemia Treatment Midstream Analysis
- 12.4 Critical Limb Ischemia Treatment Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Critical Limb Ischemia Treatment . Industry analysis & Market Report on Critical Limb Ischemia Treatment is a syndicated market report, published as Global Critical Limb Ischemia Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Critical Limb Ischemia Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
